AI Tokens
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Adjusted Financial Ratios

Microsoft Excel

Adjusted Financial Ratios (Summary)

Biogen Inc., Financial Ratios: Reported vs. Adjusted

Biogen Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Activity Ratio
Total Asset Turnover
Reported 0.46 0.55 0.53 0.53 0.52
Adjusted 0.49 0.58 0.60 0.57 0.52
Liquidity Ratio
Current Ratio
Reported 1.83 1.84 1.72 2.32 2.34
Adjusted 1.84 1.85 1.73 2.33 2.35
Solvency Ratios
Debt to Equity
Reported 0.67 0.69 0.45 0.46 0.47
Adjusted 0.75 0.76 0.50 0.51 0.53
Debt to Capital
Reported 0.40 0.41 0.31 0.31 0.32
Adjusted 0.43 0.43 0.33 0.34 0.35
Financial Leverage
Reported 2.19 2.30 2.04 1.94 1.88
Adjusted 2.19 2.24 1.86 1.89 1.94
Profitability Ratios
Net Profit Margin
Reported 14.17% 29.76% 40.96% 32.93% 20.69%
Adjusted 13.57% 30.11% 42.19% 34.54% 22.43%
Return on Equity (ROE)
Reported 14.28% 37.39% 44.13% 33.98% 20.13%
Adjusted 14.51% 38.96% 46.81% 37.03% 22.62%
Return on Assets (ROA)
Reported 6.52% 16.25% 21.62% 17.52% 10.73%
Adjusted 6.63% 17.38% 25.23% 19.62% 11.66%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


The financial performance from 2017 to 2021 is characterized by a period of significant profitability expansion peaking in 2019, followed by a sharp contraction in margins and returns by 2021. While liquidity remained stable, there was a notable increase in leverage beginning in 2020.

Profitability and Returns
A pronounced bell-shaped trend is evident across all profitability metrics. Reported net profit margin rose from 20.69% in 2017 to a peak of 40.96% in 2019, before declining sharply to 14.17% by 2021. This trajectory is mirrored in the Return on Equity (ROE) and Return on Assets (ROA), both of which peaked in 2019 at 44.13% and 21.62%, respectively, and fell to 14.28% and 6.52% by the end of the period. Adjusted figures consistently show slightly higher profitability and return levels than reported figures, though they follow the same downward trend after 2019.
Solvency and Leverage
The capital structure remained relatively stable between 2017 and 2019, with the reported debt to equity ratio fluctuating minimally around 0.45 to 0.47. However, a significant shift occurred in 2020, where the reported debt to equity ratio increased to 0.69 and the reported debt to capital ratio rose to 0.41. Financial leverage also peaked in 2020 at 2.30. These metrics saw a slight moderation in 2021 but remained substantially higher than the 2017-2019 baseline, indicating an increased reliance on debt financing in the latter part of the period.
Operational Efficiency and Liquidity
Asset utilization showed moderate growth initially, with adjusted total asset turnover increasing from 0.52 in 2017 to 0.60 in 2019. However, efficiency declined toward the end of the period, with the reported turnover dropping to 0.46 in 2021. Liquidity experienced a contraction in 2019, where the reported current ratio fell from 2.34 in 2017 to 1.72, before stabilizing around 1.83 through 2021. Despite this decline, the current ratio remained well above 1.0, suggesting the maintenance of an adequate short-term liquidity position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Revenue 10,981,700 13,444,600 14,377,900 13,452,900 12,273,900
Total assets 23,877,300 24,618,900 27,234,300 25,288,900 23,652,600
Activity Ratio
Total asset turnover1 0.46 0.55 0.53 0.53 0.52
Adjusted
Selected Financial Data (US$ in thousands)
Revenue 10,981,700 13,444,600 14,377,900 13,452,900 12,273,900
Adjusted total assets2 22,500,200 23,291,000 24,042,700 23,677,835 23,611,129
Activity Ratio
Adjusted total asset turnover3 0.49 0.58 0.60 0.57 0.52

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Total asset turnover = Revenue ÷ Total assets
= 10,981,700 ÷ 23,877,300 = 0.46

2 Adjusted total assets. See details »

3 2021 Calculation
Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 10,981,700 ÷ 22,500,200 = 0.49


The financial performance from 2017 to 2021 exhibits a fluctuating trend in asset utilization, with a notable peak in efficiency occurring in 2019 followed by a significant decline. The relationship between revenue generation and the asset base indicates a period of optimization followed by a contraction in operational productivity.

Adjusted Total Asset Turnover Trend
The adjusted total asset turnover ratio experienced a steady increase from 0.52 in 2017 to a peak of 0.60 in 2019. This improvement suggests an enhanced ability to generate revenue from the adjusted asset base during this period. However, a subsequent decline was observed, with the ratio falling to 0.58 in 2020 and further dropping to 0.49 by the end of 2021, marking the lowest efficiency level within the analyzed five-year period.
Comparative Analysis of Reported versus Adjusted Ratios
A consistent divergence exists between reported and adjusted total asset turnover. While both metrics follow a similar trajectory, the adjusted ratio remains higher than the reported ratio from 2018 through 2021. This indicates that the adjustments made to the total asset base removed certain items that would otherwise dilute the perceived efficiency of the company's asset utilization.
Revenue and Asset Correlation
The peak in adjusted total asset turnover in 2019 directly correlates with the maximum revenue reported during the period, which reached 14.38 billion US dollars. Conversely, the sharp decrease in the turnover ratio in 2021 to 0.49 is primarily driven by a substantial contraction in revenue to 10.98 billion US dollars. This decline in revenue occurred more rapidly than the reduction in adjusted total assets, which fell from 24.04 billion US dollars in 2019 to 22.50 billion US dollars in 2021, resulting in diminished asset productivity.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Current Ratio

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Current assets 7,856,500 6,887,100 8,381,800 7,640,900 7,873,300
Current liabilities 4,298,200 3,742,200 4,863,800 3,295,200 3,368,200
Liquidity Ratio
Current ratio1 1.83 1.84 1.72 2.32 2.34
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted current assets2 7,894,500 6,928,700 8,422,300 7,675,600 7,919,300
Adjusted current liabilities3 4,298,200 3,742,200 4,863,800 3,295,200 3,367,700
Liquidity Ratio
Adjusted current ratio4 1.84 1.85 1.73 2.33 2.35

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Current ratio = Current assets ÷ Current liabilities
= 7,856,500 ÷ 4,298,200 = 1.83

2 Adjusted current assets. See details »

3 Adjusted current liabilities. See details »

4 2021 Calculation
Adjusted current ratio = Adjusted current assets ÷ Adjusted current liabilities
= 7,894,500 ÷ 4,298,200 = 1.84


The adjusted current ratio reflects a period of fluctuation in short-term liquidity between 2017 and 2021. The ratio began at a peak of 2.35 in 2017 and experienced a notable contraction, reaching a low of 1.73 in 2019, before stabilizing around 1.84 to 1.85 in the subsequent two years.

Liquidity Trend Analysis
A significant reduction in the adjusted current ratio is observed between 2018 and 2019, moving from 2.33 to 1.73. This decline is primarily attributed to a substantial increase in adjusted current liabilities, which rose from 3,295,200 thousand US$ to 4,863,800 thousand US$ during that period. While current assets increased slightly in 2019, the growth in liabilities outpaced asset growth, thereby compressing the liquidity margin.
Asset and Liability Dynamics
Adjusted current assets remained relatively volatile, peaking in 2019 at 8,422,300 thousand US$ before dropping to 6,928,700 thousand US$ in 2020. A recovery in asset levels to 7,894,500 thousand US$ by 2021, coupled with a moderate reduction in liabilities in 2020, helped stabilize the adjusted current ratio above 1.80. Despite these fluctuations, the ratio consistently remained well above 1.0, indicating a sustained capacity to meet short-term obligations.
Comparison of Reported and Adjusted Metrics
There is a minimal variance between the reported current ratio and the adjusted current ratio across all five years. The adjusted figures are consistently slightly higher than the reported figures, resulting from adjusted current assets being marginally higher than reported current assets, while adjusted current liabilities remain virtually identical to reported liabilities. This suggests that the adjustments made to the financial data have a negligible impact on the overall interpretation of the short-term solvency position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total debt 7,273,100 7,426,200 5,954,800 5,936,500 5,938,200
Total Biogen Inc. shareholders’ equity 10,896,200 10,700,300 13,343,200 13,039,600 12,612,800
Solvency Ratio
Debt to equity1 0.67 0.69 0.45 0.46 0.47
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 7,692,600 7,911,400 6,441,100 6,444,635 6,446,629
Adjusted total equity3 10,277,100 10,391,100 12,958,300 12,548,600 12,171,400
Solvency Ratio
Adjusted debt to equity4 0.75 0.76 0.50 0.51 0.53

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Debt to equity = Total debt ÷ Total Biogen Inc. shareholders’ equity
= 7,273,100 ÷ 10,896,200 = 0.67

2 Adjusted total debt. See details »

3 Adjusted total equity. See details »

4 2021 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= 7,692,600 ÷ 10,277,100 = 0.75


The financial leverage profile exhibited a period of stability and gradual improvement from 2017 through 2019, followed by a significant increase in leverage beginning in 2020. The adjusted debt to equity ratio reflects a higher leverage position than the reported figures across all observed years, indicating that adjustments to debt and equity accounts consistently intensify the perceived risk profile of the capital structure.

Adjusted Debt Trends
Adjusted total debt remained relatively stagnant between 2017 and 2019, hovering around 6.4 billion US dollars. A substantial increase occurred in 2020, with debt rising to 7.9 billion US dollars, before experiencing a slight moderation to 7.6 billion US dollars by the end of 2021.
Adjusted Equity Trends
Adjusted total equity showed a steady upward trajectory from 2017 to 2019, increasing from 12.1 billion US dollars to 12.9 billion US dollars. This trend reversed sharply in 2020, with equity falling to 10.3 billion US dollars, and continuing a slight downward movement to 10.2 billion US dollars in 2021.
Adjusted Debt to Equity Ratio Analysis
The adjusted debt to equity ratio declined marginally from 0.53 in 2017 to 0.50 in 2019, signaling a strengthening balance sheet. However, a sharp inflection point occurred in 2020, where the ratio spiked to 0.76. This increase was driven by the simultaneous effect of rising adjusted debt and falling adjusted equity. The ratio remained nearly unchanged in 2021, closing at 0.75.
Comparison Between Reported and Adjusted Metrics
A consistent variance is observed between reported and adjusted leverage metrics. The adjusted debt to equity ratio is systematically higher than the reported ratio for every year in the sequence. For instance, in 2020, the reported ratio was 0.69, while the adjusted ratio was 0.76, suggesting that the adjustments account for approximately 0.07 to 0.09 points of additional leverage.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Debt to Capital

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total debt 7,273,100 7,426,200 5,954,800 5,936,500 5,938,200
Total capital 18,169,300 18,126,500 19,298,000 18,976,100 18,551,000
Solvency Ratio
Debt to capital1 0.40 0.41 0.31 0.31 0.32
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 7,692,600 7,911,400 6,441,100 6,444,635 6,446,629
Adjusted total capital3 17,969,700 18,302,500 19,399,400 18,993,235 18,618,029
Solvency Ratio
Adjusted debt to capital4 0.43 0.43 0.33 0.34 0.35

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Debt to capital = Total debt ÷ Total capital
= 7,273,100 ÷ 18,169,300 = 0.40

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2021 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 7,692,600 ÷ 17,969,700 = 0.43


The financial leverage profile remained relatively stable between 2017 and 2019, followed by a marked increase in the debt-to-capital ratio during the 2020 and 2021 fiscal years.

Adjusted Debt to Capital Ratio Trend
The adjusted ratio exhibited a slight downward trajectory from 2017 to 2019, moving from 0.35 to 0.33. A significant upward shift occurred in 2020, with the ratio rising to 0.43, a level that was maintained through the end of 2021. This indicates a substantial increase in the proportion of debt relative to total capital starting in 2020.
Adjusted Total Debt Dynamics
Adjusted total debt remained nearly constant from 2017 through 2019, holding steady at approximately 6.44 billion US dollars. A sharp increase was recorded in 2020, where debt rose to 7.91 billion US dollars, before experiencing a slight moderation to 7.69 billion US dollars in 2021.
Adjusted Total Capital Trends
Total adjusted capital increased gradually from 18.62 billion US dollars in 2017 to a peak of 19.40 billion US dollars in 2019. This trend reversed in 2020, with capital falling to 18.30 billion US dollars, and continuing to decline to 17.97 billion US dollars by the end of 2021. The simultaneous increase in debt and decrease in capital contributed to the overall rise in the leverage ratio.
Analysis of Reported versus Adjusted Figures
The adjusted debt to capital ratio is consistently higher than the reported ratio across all observed periods. For example, by December 31, 2021, the adjusted ratio was 0.43 compared to the reported ratio of 0.40. This persistent variance suggests that the adjustments applied to the debt and capital figures result in a higher perceived level of leverage than what is presented in the standard reported figures.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total assets 23,877,300 24,618,900 27,234,300 25,288,900 23,652,600
Total Biogen Inc. shareholders’ equity 10,896,200 10,700,300 13,343,200 13,039,600 12,612,800
Solvency Ratio
Financial leverage1 2.19 2.30 2.04 1.94 1.88
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total assets2 22,500,200 23,291,000 24,042,700 23,677,835 23,611,129
Adjusted total equity3 10,277,100 10,391,100 12,958,300 12,548,600 12,171,400
Solvency Ratio
Adjusted financial leverage4 2.19 2.24 1.86 1.89 1.94

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Financial leverage = Total assets ÷ Total Biogen Inc. shareholders’ equity
= 23,877,300 ÷ 10,896,200 = 2.19

2 Adjusted total assets. See details »

3 Adjusted total equity. See details »

4 2021 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= 22,500,200 ÷ 10,277,100 = 2.19


The financial structure from 2017 to 2021 demonstrates a transition from a period of asset growth and leverage optimization to a phase of balance sheet contraction and increased leverage. Total assets and equity peaked in 2019 before experiencing a significant decline in 2020, which fundamentally altered the leverage profile of the organization.

Adjusted Financial Leverage Trends
Between 2017 and 2019, adjusted financial leverage followed a consistent downward trajectory, decreasing from 1.94 to 1.86. This suggests an improvement in the risk profile during this period. However, this trend reversed sharply in 2020, with the ratio spiking to 2.24, before slightly moderating to 2.19 by the end of 2021.
Equity and Asset Dynamics
A notable contraction in adjusted total equity occurred between 2019 and 2020, falling from approximately 12.96 billion US$ to 10.39 billion US$. This reduction in the equity base served as the primary driver for the increase in financial leverage observed in 2020, as the equity cushion diminished relative to the adjusted asset base.
Comparative Analysis of Reported vs. Adjusted Leverage
A divergence is observed between reported and adjusted leverage from 2017 to 2019; while reported leverage rose from 1.88 to 2.04, adjusted leverage fell. This indicates that the adjustments removed specific balance sheet items that were inflating the reported leverage. By 2021, this divergence disappeared, as both reported and adjusted financial leverage converged at a ratio of 2.19.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income attributable to Biogen Inc. 1,556,100 4,000,600 5,888,500 4,430,700 2,539,100
Revenue 10,981,700 13,444,600 14,377,900 13,452,900 12,273,900
Profitability Ratio
Net profit margin1 14.17% 29.76% 40.96% 32.93% 20.69%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 1,490,700 4,048,800 6,065,800 4,646,200 2,753,500
Revenue 10,981,700 13,444,600 14,377,900 13,452,900 12,273,900
Profitability Ratio
Adjusted net profit margin3 13.57% 30.11% 42.19% 34.54% 22.43%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Net profit margin = 100 × Net income attributable to Biogen Inc. ÷ Revenue
= 100 × 1,556,100 ÷ 10,981,700 = 14.17%

2 Adjusted net income. See details »

3 2021 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × 1,490,700 ÷ 10,981,700 = 13.57%


Biogen Inc. exhibited a bell-shaped trend in profitability between 2017 and 2021, characterized by a period of rapid margin expansion followed by a significant contraction in both revenue and net income.

Revenue and Net Income Trajectory
Revenue grew steadily from US$ 12.27 billion in 2017 to a peak of US$ 14.38 billion in 2019, before declining to US$ 10.98 billion by the end of 2021. This trend was mirrored and amplified in the adjusted net income, which rose from US$ 2.75 billion in 2017 to a high of US$ 6.07 billion in 2019, before experiencing a sharp decline to US$ 1.49 billion in 2021.
Adjusted Net Profit Margin Volatility
The adjusted net profit margin demonstrated significant fluctuations over the five-year period. A strong upward trend was observed from 2017 to 2019, with the margin increasing from 22.43% to a peak of 42.19%. This indicates a phase of high operational efficiency or favorable cost structures. However, this was followed by a steep decline, with the margin falling to 30.11% in 2020 and further eroding to 13.57% in 2021.
Comparison of Reported and Adjusted Metrics
Adjusted and reported net profit margins moved in close correlation throughout the period. Between 2017 and 2020, the adjusted net profit margin remained consistently higher than the reported margin. However, by December 31, 2021, this relationship inverted; the adjusted net profit margin of 13.57% fell below the reported margin of 14.17%, indicating that the adjustments applied in the final year negatively impacted the net profit calculation.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income attributable to Biogen Inc. 1,556,100 4,000,600 5,888,500 4,430,700 2,539,100
Total Biogen Inc. shareholders’ equity 10,896,200 10,700,300 13,343,200 13,039,600 12,612,800
Profitability Ratio
ROE1 14.28% 37.39% 44.13% 33.98% 20.13%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 1,490,700 4,048,800 6,065,800 4,646,200 2,753,500
Adjusted total equity3 10,277,100 10,391,100 12,958,300 12,548,600 12,171,400
Profitability Ratio
Adjusted ROE4 14.51% 38.96% 46.81% 37.03% 22.62%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
ROE = 100 × Net income attributable to Biogen Inc. ÷ Total Biogen Inc. shareholders’ equity
= 100 × 1,556,100 ÷ 10,896,200 = 14.28%

2 Adjusted net income. See details »

3 Adjusted total equity. See details »

4 2021 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted total equity
= 100 × 1,490,700 ÷ 10,277,100 = 14.51%


The Adjusted Return on Equity (ROE) exhibited a bell-shaped trajectory between 2017 and 2021, characterized by a period of aggressive growth followed by a significant contraction. The ratio ascended from 22.62% in 2017 to a peak of 46.81% in 2019, before declining sharply to 14.51% by the end of 2021.

Profitability Drivers
The upward trend in Adjusted ROE through 2019 was primarily driven by a substantial increase in adjusted net income, which rose from US$ 2.75 billion in 2017 to a peak of US$ 6.07 billion in 2019. Conversely, the subsequent decline in ROE was precipitated by a steep reduction in adjusted net income, which fell to US$ 1.49 billion in 2021, representing a significant erosion of earnings power.
Equity Base Stability
Adjusted total equity remained relatively stable during the growth phase, increasing slightly from US$ 12.17 billion in 2017 to US$ 12.96 billion in 2019. A contraction in the equity base occurred in 2020 and 2021, with adjusted total equity ending at US$ 10.28 billion. While equity decreased, the magnitude of the decline in net income was far more pronounced, identifying earnings volatility as the primary driver of the ROE fluctuations.
Reported vs. Adjusted Performance
Adjusted ROE consistently tracked higher than reported ROE from 2017 through 2020, suggesting that non-recurring items or specific accounting adjustments positively impacted the normalized view of profitability. By 2021, the gap between reported ROE (14.28%) and adjusted ROE (14.51%) narrowed significantly, indicating a closer alignment between reported and normalized financial performance during the period of lowest profitability.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income attributable to Biogen Inc. 1,556,100 4,000,600 5,888,500 4,430,700 2,539,100
Total assets 23,877,300 24,618,900 27,234,300 25,288,900 23,652,600
Profitability Ratio
ROA1 6.52% 16.25% 21.62% 17.52% 10.73%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 1,490,700 4,048,800 6,065,800 4,646,200 2,753,500
Adjusted total assets3 22,500,200 23,291,000 24,042,700 23,677,835 23,611,129
Profitability Ratio
Adjusted ROA4 6.63% 17.38% 25.23% 19.62% 11.66%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
ROA = 100 × Net income attributable to Biogen Inc. ÷ Total assets
= 100 × 1,556,100 ÷ 23,877,300 = 6.52%

2 Adjusted net income. See details »

3 Adjusted total assets. See details »

4 2021 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × 1,490,700 ÷ 22,500,200 = 6.63%


The Adjusted Return on Assets (ROA) exhibited a parabolic trend between 2017 and 2021, characterized by a period of significant expansion followed by a sharp contraction. Asset utilization efficiency peaked in 2019 before declining steadily over the subsequent two fiscal years.

Growth Phase (2017–2019)
A substantial upward trajectory is observed in the Adjusted ROA, which rose from 11.66% in 2017 to a peak of 25.23% in 2019. This increase was primarily driven by a strong surge in Adjusted Net Income, which grew from US$ 2,753.5 million to US$ 6,065.8 million during this period. This growth in earnings significantly outpaced the marginal increase in Adjusted Total Assets, indicating high operational efficiency and effective deployment of resources to generate profit.
Contraction Phase (2020–2021)
Following the 2019 peak, a pronounced downward trend occurred, with the Adjusted ROA falling to 17.38% in 2020 and further dropping to 6.63% by December 31, 2021. This decline is attributed to a steep reduction in Adjusted Net Income, which plummeted to US$ 1,490.7 million in 2021. Although Adjusted Total Assets also decreased from US$ 24.04 billion in 2019 to US$ 22.50 billion in 2021, the contraction in profitability was far more severe, leading to the erosion of the asset return ratio.
Comparison of Reported and Adjusted Metrics
The Adjusted ROA remained consistently higher than the Reported ROA from 2017 through 2020, suggesting that the exclusion of certain non-recurring items or accounting adjustments presented a more favorable view of asset productivity. However, by 2021, the gap between the Reported ROA (6.52%) and the Adjusted ROA (6.63%) narrowed significantly, indicating that the factors driving the decline in profitability were largely operational or reflected in both reporting standards.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?